These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2831669)
21. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates. Horowitz B; Rywkin S; Margolis-Nunno H; Williams B; Geacintov N; Prince AM; Pascual D; Ragno G; Valeri CR; Huima-Byron T Blood Cells; 1992; 18(1):141-9; discussion 150. PubMed ID: 1617188 [TBL] [Abstract][Full Text] [Related]
22. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Lenard J; Rabson A; Vanderoef R Proc Natl Acad Sci U S A; 1993 Jan; 90(1):158-62. PubMed ID: 7678335 [TBL] [Abstract][Full Text] [Related]
23. Inactivation of lipid-enveloped viruses in proteins by caprylate. Lundblad JL; Seng RL Vox Sang; 1991; 60(2):75-81. PubMed ID: 2031341 [TBL] [Abstract][Full Text] [Related]
24. Elimination of viruses (human immunodeficiency, hepatitis B, vesicular stomatitis and Sindbis viruses) from an intravenous immunoglobulin preparation. Hamamoto Y; Harada S; Yamamoto N; Uemura Y; Goto T; Suyama T Vox Sang; 1987; 53(2):65-9. PubMed ID: 2825431 [TBL] [Abstract][Full Text] [Related]
25. Inactivation of lipid-enveloped and non-lipid-enveloped model viruses in normal human plasma by crosslinked starch-iodine. Highsmith FA; Xue H; Caple M; Walthall B; Drohan WN; Shanbrom E Transfusion; 1994 Apr; 34(4):322-7. PubMed ID: 8178330 [TBL] [Abstract][Full Text] [Related]
26. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia. Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light. Benade LE; Shumaker J; Xu Y; Chen X; Dodd RY Transfusion; 1994 Aug; 34(8):680-4. PubMed ID: 8073484 [TBL] [Abstract][Full Text] [Related]
28. Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection of red cells but not of vesicular stomatitis virus with a water-soluble analogue of vitamin E. Ben-Hur E; Rywkin S; Rosenthal I; Geacintov NE; Horowitz B Transfusion; 1995 May; 35(5):401-6. PubMed ID: 7740611 [TBL] [Abstract][Full Text] [Related]
29. Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin. Prince AM; Pascual D; Meruelo D; Liebes L; Mazur Y; Dubovi E; Mandel M; Lavie G Photochem Photobiol; 2000 Feb; 71(2):188-95. PubMed ID: 10687393 [TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates. Mannucci PM Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048 [TBL] [Abstract][Full Text] [Related]
32. Laboratory and preclinical evaluation of the virus safety of coagulation factor concentrates. Horowitz B; Prince AM Dev Biol Stand; 1987; 67():291-302. PubMed ID: 3609483 [TBL] [Abstract][Full Text] [Related]
33. New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates. Rywkin S; Ben-Hur E; Malik Z; Prince AM; Li YS; Kenney ME; Oleinick NL; Horowitz B Photochem Photobiol; 1994 Aug; 60(2):165-70. PubMed ID: 7938215 [TBL] [Abstract][Full Text] [Related]
34. [Comparative study of concentrated blood derivatives of factor VIII]. Baklaja R; Miletić V; Stajić M; Cvetković V; Grozdanić V Bilt Hematol Transfuz; 1984; 12(2):91-103. PubMed ID: 6441567 [TBL] [Abstract][Full Text] [Related]
35. Inactivation of enveloped viruses in human bodily fluids by purified lipids. Isaacs CE; Kim KS; Thormar H Ann N Y Acad Sci; 1994 Jun; 724():457-64. PubMed ID: 8030973 [TBL] [Abstract][Full Text] [Related]
36. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates. Goldsmith JC Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015 [TBL] [Abstract][Full Text] [Related]
37. Virus removal or inactivation in hemoglobin solutions by ultrafiltration or detergent/solvent treatment. Bechtel MK; Bagdasarian A; Olson WP; Estep TN Biomater Artif Cells Artif Organs; 1988; 16(1-3):123-8. PubMed ID: 2846096 [TBL] [Abstract][Full Text] [Related]
38. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates]. Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297 [TBL] [Abstract][Full Text] [Related]
39. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate. Prince AM; Horowitz B; Brotman B Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224 [TBL] [Abstract][Full Text] [Related]
40. Biodistribution and virus inactivation efficacy of a silicon phthalocyanine in red blood cell concentrates as a function of delivery vehicle. Ben-Hur E; Zuk MM; Chin S; Banerjee D; Kenney ME; Horowitz B Photochem Photobiol; 1995 Sep; 62(3):575-9. PubMed ID: 8570715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]